| Stage | LLY | % of rev | PGEN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $24.4B | 100.00% | $74M | 100.00% | LLY ×329.03 |
| Gross profit | $20.5B | 83.88% | $68M | 91.22% | PGEN +7.3pp |
| Operating income | $8.6B | 35.28% | $39M | 52.13% | PGEN +16.8pp |
| Pre-tax income | $8.4B | 34.46% | $36M | 48.51% | PGEN +14.1pp |
| Net income | $6.5B | 26.44% | $36M | 48.24% | PGEN +21.8pp |
| Stage | LLY | PGEN | Gap · A − B |
|---|---|---|---|
| Revenue | $24.4B100.00% | $74M100.00% | LLY ×329.03 |
| Gross profit | 83.88%$20.5B | 91.22%$68M | PGEN +7.3pp |
| Operating income | 35.28%$8.6B | 52.13%$39M | PGEN +16.8pp |
| Pre-tax income | 34.46%$8.4B | 48.51%$36M | PGEN +14.1pp |
| Net income |
| 26.44%$6.5B |
| 48.24%$36M |
| PGEN +21.8pp |
No shared counterparties.